Life Science Invest
Investing in the future
Aktuellt
Acorai closes $4.5M investment from the European Innovation Council (EIC) Fund
28 november, 2024 | ScaleUp (LSI Delta), Nyheter
LSI portfolio company Acorai, a Swedish developer and manufacturer of innovative devices for heart failure management, announced the closing of a $4.5M investment from the EIC Fund, Taiwan Medical University, and private investors. The capital will be used to complete...
LSI Epsilon invest in Videm
15 november, 2024 | LSI Epsilon
We are super happy to present VIDEM, LSI Epsilons fifth investment. Videm provides accurate, accessible and affordable disease diagnostics to improve global health. You will also find Videm on NyTeknik - First with news about technology and IT.s newly published list...
LSI Epsilon invest in BrainZell
6 november, 2024 | LSI Epsilon
We are happy to welcome BrainZell to the LSI Epsilon family. By replacing and reducing traditional animal testing with cutting-edge human cell models, BrainZell are shaping a more sustainable future for medicine. We are looking forward to work with Petra Szeszula,...
Investment strategy
There are many start-up companies within Life Science. We cannot evaluate them all, so we focus on finding companies within our niche. Which companies, then, are of interest to us?
Our angels
Life Science Invests angels have very broad and deep experience within Life Science.
































































































